Kristin Yarema - Chief Commercial Officer, Atara Biotherapeutics, Inc

As of March 3, 2022


Kristin Yarema Net Worth

  • Net worth is estimated to be at least $806.92K
  • Owns at least 125,882 units of Atara Biotherapeutics, Inc stock
  • Sold an estimated value of $11.07K in the last 2 years at Atara Biotherapeutics, Inc

Kristin Yarema Compensation at Atara Biotherapeutics, Inc in 2020

  • Earned a $368,308 salary and a $147 bonus
  • Rewarded $668,250 in stock value and options
  • Received a total compensation of $2,436,407

Kristin Yarema Trading

  • Largest purchase of shares was 34,354 units , worth over $500.37K on June 15, 2021
  • Largest sale of shares was 761 units , worth over $11.07K on May 20, 2021
  • In total has made about 6 transactions over 2 years
  • Usually trades in March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kristin Yarema Mailing Address

  • Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd., Suite 900 South San Francisco CA 94080 CA

Atara Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm

Atara Biotherapeutics, Inc Insider Trading

  • The most recent transaction was 3,223 units sold on May 19, 2022 by Amar Murugan worth over $17.13K
  • In the last 8 years, insiders at Atara Biotherapeutics, Inc sold an estimated value of $72.85M and bought an estimated value of $10.47M
  • The most active traders are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer
  • Insider trading is most common in February, with the busiest year in 2018

Atara Biotherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1